Italia markets close in 7 hours 39 minutes
FTSE MIB
34.297,33 +191,32 (+0,56%) Dow Jones
39.308,00 -23,90 (-0,06%) Nasdaq
18.188,30 +159,54 (+0,88%) Nikkei 225
40.912,37 -1,28 (-0,00%) Petrolio
84,19 +0,31 (+0,37%) Bitcoin EUR
50.157,73 -3.752,02 (-6,96%)
TEVA Jan 2025 24.000 call
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 12:39PM EDT. Mercato aperto.
| Chiusura precedente | 0,4200 |
| Aperto | 0,4200 |
| Denaro | 0,2900 |
| Domanda | 0,3900 |
| Prezzo d'esercizio | 24,00 |
| Scadenza | 2025-01-17 |
| Min-Max giorno | 0,4200 - 0,4200 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 7 |
GlobeNewswireTeva Pharmaceuticals and Alvotech Provide Update on Strategic Biosimilars Partnership
TEL AVIV, Israel and PARSIPPANY, N.J. and REYKJAVIK, Iceland, July 24, 2023 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), a global leader in generic and innovative medicines and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that they have agreed to expand their existing strategic partnership agreement.
© 2024 Yahoo. Tutti i diritti riservati.